A New Kind of MRI Scan for People With Primary CNS Lymphoma
Official title: Feasibility of Acquiring Hyperpolarized Imaging in Patients With Primary CNS Lymphoma
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
This study is testing a special MRI scan to see if it can spot brain lymphoma and show how it responds to treatment.
Read our full plain-language summary
What the trial team says
This phase I trial evaluates the feasibility of using hyperpolarized carbon C 13 pyruvate magnetic resonance imaging (MRI) in diagnosing patients with primary central nervous system lymphoma. This trial aims to see whether MRI using hyperpolarized carbon-13 pyruvate is safe and useful for detecting central nervous system lymphoma and evaluating response to treatment.
Key facts
- Registry number
- NCT04656431
- Stage of testing
- Phase 1
- Conditions studied
- Primary CNS Lymphoma
Where it is running
This trial lists 1 site.
-
California
- University of California, San Francisco (San Francisco)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.